Cellular Response to Misfolded Rhodopsins.
Cellular Response to Misfolded Rhodopsins.
批准号:
8901175
负责人:
HYUNG D RYOO
金额:
$41.53万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2018-07-31
关键词:
AffectAgeAllelesAmino Acid SubstitutionApoptoticAreaBlindnessCDK5 geneCarboxypeptidaseCell DeathCell Death Signaling ProcessCellsCellular StressCyclin-Dependent KinasesCytoplasmDataDevelopmentDiseaseDrosophila genusEndoplasmic ReticulumEventExhibitsGene ProteinsGenesGeneticGenetic ScreeningGenetic TranscriptionGoalsHereditary DiseaseHomologous GeneHumanKnowledgeLongevityMediatingMediator of activation proteinMitochondriaModelingMutationOrganismOutcomeOuter Mitochondrial MembranePERK kinasePathologyPathway interactionsPatientsPeptide HydrolasesPhosphotransferasesPhotoreceptorsPlayProcessPropertyProteinsQuality ControlRNA InterferenceRegulationResistanceRetinal DegenerationRetinitis PigmentosaRetinoidsRhodopsinRoleSignal TransductionStressSystemTestingTherapeuticTranscriptTranslatingTranslational RepressionTranslationsage relatedbasebiological adaptation to stresscopingendoplasmic reticulum stressinhibitor/antagonistinterestmulticatalytic endopeptidase complexmutantnovel therapeuticsoverexpressionpro-apoptotic proteinprotective effectprotein foldingprotein misfoldingpublic health relevanceresponsereticulum celltoolubiquitin ligase
中文摘要
描述(由申请人提供):该项目的长期目标是了解细胞如何应对常染色体显性视网膜色素变性(ADRP)果蝇模型中与年龄相关的视网膜变性相关的视紫红质-1 (Rh-1)蛋白突变。该模型中的Rh-1等位基因破坏编码蛋白的折叠特性,并对内质网(ER)施加压力。健康的年轻细胞表现出强大的内质网应激反应机制,使受影响的光感受器存活到老年。另一方面,衰老细胞通过激活细胞死亡途径屈服于压力,导致与年龄相关的视网膜变性。更好地了解这些途径可能有助于开发针对这种疾病的有效治疗策略。通过我们独特的基于果蝇的方法,我们确定了许多意想不到的突变Rh-1的细胞反应机制,这些机制可能在ADRP中发挥重要作用。在这里,我们提出了三个具体目标来研究这些机制。在Aim 1中,我们计划研究细胞如何降解错误折叠的视紫红质以减少内质网中的应激。我们之前已经证实,参与这一过程的中心泛素连接酶HRD1可以显著延缓果蝇ADRP模型的视网膜变性过程。HRD1需要其他蛋白质的合作来帮助识别和降解错误折叠的Rh-1。通过遗传筛选,我们确定了一种特征不佳的羧肽酶,作为帮助减少错误折叠的Rh-1水平的最有效因素之一。在这里,我们提出验证hrd1介导的错误折叠视紫红质的降解需要这种功能未知的羧肽酶这一有趣的想法。在目标2中,我们建议确定翻译抑制剂在内质网应激反应中的作用。翻译抑制是细胞应激的常见结果,特别是在内质网中错误折叠的蛋白质过载时,细胞激活翻译抑制剂PERK以减轻内质网蛋白质折叠系统的负担。出乎意料的是,我们发现另一种翻译抑制剂4E-BP在PERK的下游被诱导。由于4E-BP具有增强抗逆性和延长寿命的作用,我们计划在ADRP模型中测试4E-BP诱导的功能意义。此外,我们建议确定4E-BP如何保护细胞免受内质网应激。在Aim 3中,我们提出研究内质网应激如何诱导细胞死亡。许多细胞死亡调节因子的功能定位于线粒体外膜,我们假设一个特定的细胞死亡途径将应激信号从内质网传递到线粒体。通过基因筛选,我们发现了两种细胞周期蛋白依赖性激酶(CDKs),它们出乎意料地参与了这种细胞死亡信号传导。在这里,我们提出测试这些CDKs形成线性途径的想法,促进线粒体外膜的促凋亡事件。我们将进一步研究这些基因在果蝇ADRP模型中与年龄相关的视网膜变性中的作用。这一建议的成功结果有望为内质网应激反应的三个鲜为人知的领域带来概念上的进步,这些领域与ADRP的病理直接相关。
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to understand how cells cope with mutant Rhodopsin-1 (Rh-1) proteins that underlie age-related retinal degeneration in the Drosophila model for Autosomal Dominant Retinitis Pigmentosa (ADRP). The Rh-1 alleles in this model impair the encoded protein's folding property and impose stress to the endoplasmic reticulum (ER). Healthy young cells exhibit robust ER stress-response mechanisms that allow the afflicted photoreceptors to survive until old age. On the other hand, old cells succumb to stress by activating cell death pathways, leading to age-related retinal degeneration. A better understanding of these pathways may allow the development of effective therapeutic strategies against this disease. Through our unique Drosophila-based approach, we identified a number of cellular response mechanisms to mutant Rh-1 that were unexpected, yet likely to play important roles in ADRP. Here, we propose three Specific Aims to investigate those mechanisms. In Aim 1, we plan to examine how cells degrade misfolded rhodopsins to reduce stress in the ER. We had previously established that a central ubiquitin ligase involved in this process, HRD1, can significantly delay the course of retinal degeneration in the Drosophila ADRP model. HRD1 requires the cooperation of other proteins that help recognize and degrade misfolded Rh-1. Through a genetic screen, we identified a poorly characterized carboxypeptidase as one of the most potent factors that help reduce misfolded Rh-1 levels. Here, we propose to validate the intriguing idea that HRD1-mediated degradation of misfolded rhodopsin requires this carboxypeptidase of unknown function. In Aim 2, we propose to determine the role of translational inhibitors in the ER stress response. Translational inhibition s a common outcome of cellular stress, and specifically in response to misfolded protein overload in the ER, cells activate the translational inhibitor PERK to reduce the burden on the ER protein folding system. Unexpectedly, we discovered that another translational inhibitor, 4E-BP, is induced downstream of PERK. As 4E-BP is known for its effects in enhancing stress resistance and prolonging lifespan, we plan to test the functional significance of 4E-BP induction in the ADRP model. Moreover, we propose to determine how 4E-BP protects cells against ER stress. In Aim 3, we propose to study how ER stress induces cell death. Many cell death regulators localize to the mitochondrial outer membrane for their function, and we hypothesize that a specific cell death pathway conveys stress signals from the ER to the mitochondria. Through a genetic screen, we identified two Cyclin Dependent Kinases (CDKs) that are unexpectedly involved in this cell death signaling. Here, we propose to test the idea these CDKs form a linear pathway that promotes pro-apoptotic events at the mitochondrial outer membrane. The genes of interest here will be further examined for their roles in age-related retinal degeneration in a Drosophila model of ADRP. A successful outcome of this proposal is expected to bring conceptual advances to the three poorly understood areas of ER stress response that are directly related to the pathology of ADRP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational control of stress response signaling
-
批准号:10552193
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2023
-
负责人:HYUNG D RYOO
-
依托单位:
Translation control of stress response and innate immunity
-
批准号:10004111
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2018
-
负责人:HYUNG D RYOO
-
依托单位:
Quality control mechanisms against misfolded rhodopsins in Drosophila.
-
批准号:8664498
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2013
-
负责人:HYUNG D RYOO
-
依托单位:
Unfolded Protein Response in Eye Development and Disease
-
批准号:9759937
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2010
-
负责人:HYUNG D RYOO
-
依托单位:
Quality control mechanisms against misfolded rhodopsins in Drosophila.
-
批准号:8113397
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2010
-
负责人:HYUNG D RYOO
-
依托单位:
Cellular Response to Misfolded Rhodopsins.
-
批准号:8757005
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2010
-
负责人:HYUNG D RYOO
-
依托单位:
Quality control mechanisms against misfolded rhodopsins in Drosophila.
-
批准号:7947938
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2010
-
负责人:HYUNG D RYOO
-
依托单位:
Unfolded Protein Response in Drosophila models of Retinitis Pigmentosa
-
批准号:10735578
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2010
-
负责人:HYUNG D RYOO
-
依托单位:
Unfolded Protein Response in Eye Development and Disease
-
批准号:10171856
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2010
-
负责人:HYUNG D RYOO
-
依托单位:
Quality control mechanisms against misfolded rhodopsins in Drosophila.
-
批准号:8301711
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2010
-
负责人:HYUNG D RYOO
-
依托单位:
Coordination of Apoptosis and Cell Proliferation in Drosophila
-
批准号:7904463
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2009
-
负责人:HYUNG D RYOO
-
依托单位:
Coordination of Apoptosis and Cell Proliferation in Drosophila
-
批准号:7851531
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2007
-
负责人:HYUNG D RYOO
-
依托单位:
Coordination of Apoptosis and Cell Proliferation in Drosophila
-
批准号:8075507
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:HYUNG D RYOO
-
依托单位:
Coordination of Apoptosis and Cell Proliferation in Drosophila
-
批准号:7319607
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2007
-
负责人:HYUNG D RYOO
-
依托单位:
Coordination of Apoptosis and Cell Proliferation in Drosophila
-
批准号:7616879
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2007
-
负责人:HYUNG D RYOO
-
依托单位:
Coordination of Apoptosis and Cell Proliferation in Drosophila
-
批准号:7477989
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2007
-
负责人:HYUNG D RYOO
-
依托单位:
Metabolic Regulation in the Acute Phase
-
批准号:7848181
-
项目类别:
-
资助金额:$45.73万
-
财政年份:1993
-
负责人:HYUNG D RYOO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: